
Sign up to save your podcasts
Or


Washington correspondent John Wilkerson joins to discuss why drugmakers have not lobbied against Robert F. Kennedy Jr.'s nomination to lead the Department of Health and Human Services, despite his repeated criticisms of the pharmaceutical industry. We also bring on our colleague Jason Mast to talk about the major hurdles in the field of gene therapy and how one father is trying to overcome them.
By STAT4.5
309309 ratings
Washington correspondent John Wilkerson joins to discuss why drugmakers have not lobbied against Robert F. Kennedy Jr.'s nomination to lead the Department of Health and Human Services, despite his repeated criticisms of the pharmaceutical industry. We also bring on our colleague Jason Mast to talk about the major hurdles in the field of gene therapy and how one father is trying to overcome them.

30,676 Listeners

1,902 Listeners

499 Listeners

9,527 Listeners

6,072 Listeners

395 Listeners

61 Listeners

86 Listeners

34 Listeners

502 Listeners

5,470 Listeners

19 Listeners

48 Listeners

388 Listeners

12 Listeners